Real-World Insights from Biopharma Exec Survey — Selecting the Right CRO
One-Stop Solution for Meeting Your Needs in Outsourcing Drug Development
Altasciences recently conducted a survey to understand the challenges biopharmaceutical companies face when outsourcing their early phase drug development programs. Over 143 executives shared the important factors that guide them in the selection of a CRO partner.
Their candid testimonials are shared in this playbook, including:
- The significant challenges encountered when conducting preclinical and Phase I studies
- The unique difficulties of transitioning from preclinical to first-in-human studies
- The specific capabilities and expertise executives look for in their CRO partners
- The novel drug development solution approach for addressing the challenges encountered
Download your copy today.
![One Integrated Solution for Meeting Your Preclinical to Clinical Drug Development Needs](/sites/default/files/inline-images/Thumbnail_Biopharma_Dive_Playbook_One_Intergrated_Solution.png)
Let us help! Speak with our experts today.
You may also be interested in the following:
Webpages:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.